Taken together, these results suggest that different molecular subtypes of breast cancer express high levels of RAC1 and BRD4 and amplification of both BRD4 and RAC1 signaling correlated with decreased survival of breast cancer patients. This evidence concerns the gene RAC1 and breast cancer.